Study on use of β-blocker and resting heart rate control among patients with coronary disease in community medical institutions
10.3760/cma.j.cn114798-20220314-00181
- VernacularTitle:社区医疗机构冠心病患者β受体阻滞剂应用及心率控制情况研究
- Author:
Chenghuan WANG
1
;
Hongyan WANG
;
Yujiang LIU
;
Fengmei ZHAO
;
Yue JIANG
Author Information
1. 北京市羊坊店医院全科医学科，北京 100038
- Keywords:
Coronary heart disease;
Resting heart rate;
Hypertension;
β-blocker
- From:
Chinese Journal of General Practitioners
2022;21(12):1169-1173
- CountryChina
- Language:Chinese
-
Abstract:
A cross-sectional study was conducted on 1 052 patients with coronary heart disease (CHD) who visited 10 community health service centers in Chaoyang and Haidian districts of Beijing from March 2019 to September 2019. Basic information, medical history, cardiovascular risk factors, β-blocker use, height, weight, blood pressure level and resting heart rate were collected by face-to-face interview;biochemical tests and on-site physical examination were performed;and the influencing factors of heart rate control were analyzed by logistic regression. There were 563 males (53.5%) and 489 females(46.5%),with a mean age of (66.7±9.5) years. The rate of β-blockers use was 43.6% (459/1 052). The average resting heart rate was (70±8)/min, and only 14.5% (153/ 1 052) patients had the heart rate under control. The resting heart rate control rate in patients with β-blockers use was 17.9% (82/459), higher than that of those without β-blockers use [12.0% (71/593), χ 2=7.23, P=0.007]. Moderate leisure activities were beneficial to the control of resting heart rate ( OR=2.14, 95% CI: 1.26-3.62). The study shows that β-blockers use and resting heart rate control in CHD patients in Beijing community health institutions were both at low levels, and the resting heart rate was not well controlled even in patients taking beta-blockers.
